Aarey Drugs & Pharmaceuticals Limited has announced the publication of its audited standalone financial results for the quarter and financial year ended March 31, 2026. These results were reviewed and approved by the Board of Directors at a meeting held on Saturday, May 30, 2026. The company has published an extract of these financial results in two newspapers: "Active Times" (English) and "Mumbai Lakshadweep" (Marathi), both on June 2, 2026, in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. For the quarter ended March 31, 2026, the company reported total income of ₹18,904.29 lakh and a profit of ₹155.74 lakh. For the financial year ended March 31, 2026, the total income stood at ₹47,836.61 lakh, with a profit of ₹396.76 lakh. The detailed financial results, including other line items as per Regulation 52(4) of SEBI LODR, are available on the websites of BSE Limited and the company.
